Literature DB >> 8666897

Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.

G S Gilkeson1, P Ruiz, A M Pippen, A L Alexander, J B Lefkowith, D S Pisetsky.   

Abstract

Preautoimmune New Zealand Black/White (NZB/NZW) mice immunized with Escherichia coli (EC) double standard (ds) DNA produce antibodies that bind mammalian dsDNA and display specificities similar to spontaneous lupus anti-DNA. Since calf thymus (CT) dsDNA fails to induce these antibodies, these results suggest a special potency of foreign DNA in inducing serological manifestations of lupus in a susceptible host. To assess the effects of DNA immunization on clinical manifestations in NZB/NZW mice, we measured renal disease and survival of mice immunized with either (a) EC dsDNA as complexes with methylated bovine serum albumin (mBSA) in adjuvant; (b) CT dsDNA with mBSA in adjuvant; (c)mBSA alone in adjuvant; or (d) unimmunized. After immunization with EC dsDNA, NZB/NZW mice developed significant levels of anti-dsDNA antibodies. Nevertheless, these mice had less proteinuria, nitrate/nitrite excretion, and glomerular pathology than mice immunized with either mBSA alone, CT dsDNA/mBSA complexes, or unimmunized mice. Survival of the EC dsDNA immunized mice was significantly increased compared with the other mice. Furthermore, immunization of mice after the onset of anti-DNA production and proteinuria stabilized nephritis and prolonged survival. The improvement in renal disease occurred despite the expression of autoantibodies that bound mammalian dsDNA as well as glomerular antigens. These results suggest that bacterial DNA has immunological properties that attenuate murine lupus despite the induction of pathogenic antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666897      PMCID: PMC2192478          DOI: 10.1084/jem.183.4.1389

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

Review 1.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  The antibody response of normal mice to immunization with single-stranded DNA of various species origin.

Authors:  G S Gilkeson; J P Grudier; D S Pisetsky
Journal:  Clin Immunol Immunopathol       Date:  1989-06

3.  NIH conference. Lupus nephritis.

Authors:  J E Balow; H A Austin; G C Tsokos; T T Antonovych; A D Steinberg; J H Klippel
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

4.  Responsiveness of autoimmune and normal mice to nucleic acid antigens.

Authors:  M P Madaio; S Hodder; R S Schwartz; B D Stollar
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

5.  Polyreactive autoantibodies are nephritogenic in murine lupus nephritis.

Authors:  O G Pankewycz; P Migliorini; M P Madaio
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

6.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.

Authors:  C O Jacob; H O McDevitt
Journal:  Nature       Date:  1988-01-28       Impact factor: 49.962

7.  Spontaneous expression of antibodies to DNA of various species origin in sera of normal subjects and patients with systemic lupus erythematosus.

Authors:  D G Karounos; J P Grudier; D S Pisetsky
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

8.  Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA.

Authors:  G S Gilkeson; J P Grudier; D G Karounos; D S Pisetsky
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

9.  Induction of severe autoimmune disease in normal mice by simultaneous action of multiple immunostimulators.

Authors:  L M Hang; M T Aguado; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

10.  In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG.

Authors:  S Yamamoto; E Kuramoto; S Shimada; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1988-07
View more
  19 in total

Review 1.  Rescue of B cells from apoptosis by immune stimulatory CpG DNA.

Authors:  A M Krieg; A K Yi
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safety.

Authors:  D M Klinman; S Kamstrup; D Verthelyi; I Gursel; K J Ishii; F Takeshita; M Gursel
Journal:  Springer Semin Immunopathol       Date:  2000

3.  Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides.

Authors:  Petar Lenert; Adam Goeken; Barry S Handwerger; Robert F Ashman
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

4.  In vivo role of B lymphocytes in somatic transgene immunization.

Authors:  S Xiong; M Gerloni; M Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice.

Authors:  E Favoino; E I Favia; L Digiglio; V Racanelli; Y Shoenfeld; F Perosa
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

6.  A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells.

Authors:  Katherine Miles; Jonathan Heaney; Zaneta Sibinska; Donald Salter; John Savill; David Gray; Mohini Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-29       Impact factor: 11.205

Review 7.  Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

8.  Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

9.  TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.

Authors:  Petar Lenert; Rachel Brummel; Elizabeth H Field; Robert F Ashman
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

10.  Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.

Authors:  Hideo Yoshida; Minoru Satoh; Krista M Behney; Chee-Gun Lee; Hanno B Richards; Victoria M Shaheen; Jun-Qi Yang; Ram R Singh; Westley H Reeves
Journal:  Arthritis Rheum       Date:  2002-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.